Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Discontinued Operations: 2017-2018

Historic Cash from Discontinued Operations for Fortress Biotech (FBIO) over the last 2 years, with Dec 2018 value amounting to -$1.8 million.

  • Fortress Biotech's Cash from Discontinued Operations was N/A to $5.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.8 million for FY2018, which is 56.96% up from last year.
  • As of FY2018, Fortress Biotech's Cash from Discontinued Operations stood at -$1.8 million, which was up 56.96% from -$4.1 million recorded in FY2017.
  • Over the past 5 years, Fortress Biotech's Cash from Discontinued Operations peaked at -$1.8 million during FY2018, and registered a low of -$4.1 million during FY2017.
  • In the last 2 years, Fortress Biotech's Cash from Discontinued Operations had a median value of -$3.0 million in 2017 and averaged -$3.0 million.
  • Data for Fortress Biotech's Cash from Discontinued Operations shows a peak YoY soared of 56.96% (in 2018) over the last 5 years.
  • Over the past 2 years, Fortress Biotech's Cash from Discontinued Operations (Yearly) stood at -$4.1 million in 2017, then skyrocketed by 56.96% to -$1.8 million in 2018.